From Policy to Practice Actionable Recommendations for a Commercial Bioeconomy 2025
Page 11 of 39 · WEF_From_Policy_to_Practice_Actionable_Recommendations_for_a_Commercial_Bioeconomy_2025.pdf
Description Greater access to testbeds for commercial bio-innovation will accelerate testing
and iteration, increase engagement with regulators, and help bring breakthrough
innovations to market more quickly.
Example Co-funded by EIT Food and the European Union, Test Farms is a programme
that empowers start-ups and individuals with groundbreaking agritech solutions
to test, validate and showcase their products and services by providing ample
access to real farms in Poland, Spain and Portugal.21
Innovation testbeds and regulatory sandboxes
serve as complementary policy tools, providing
flexible, forward-thinking regulatory approaches
and encouraging collaboration between regulators
and innovators to co-develop frameworks for emerging technologies. Expanding access to
testbeds will strengthen commercial pathways,
maximize societal benefits, and enable
earlier, more accurate assessments of safety
and efficacy.
Recommendation 2
Streamlined regulatory pathways
designed for purpose
What if regulatory mechanisms were shaped
at the onset to deliver innovative outcomes
for humanity faster?
In today’s fast-moving landscape, technological
advancement often outpaces the development
of regulations. This challenge is compounded
by the cross-disciplinary nature of emerging
bio-innovations, which frequently fall outside the
scope of existing regulatory frameworks, ultimately
delaying their entry into the market.As a result, regulations often become outdated or
misaligned with emerging technologies, failing to serve
their intended purpose. For example, under certain
EU regulations, microbes are classified as chemical
pesticides, overlooking their unique biological
properties and limiting their potential.22 Persisting with
outdated, misaligned regulations stifles bio-innovation,
limiting consumers, patients and other beneficiaries
from accessing their transformative benefits. Recommendation 1
Description Streamlined, purpose-built regulatory pathways will accelerate approvals, ensure
relevant and effective safety testing, and help deliver the benefits of bio-innovation
to society more quickly.
Example The Regulatory Innovation Office (RIO) aims to position the UK as a global leader
in innovation by creating a more agile regulatory environment, ensuring that
cutting-edge technologies reach the public swiftly and safely.23 The RIO aims
to update regulations, accelerate approvals and improve coordination among
regulatory bodies.
Recommendation 2
11 From Policy to Practice: Actionable Recommendations for a Commercial Bioeconomy
Ask AI what this page says about a topic: